Health resource utilisation due to IPF exacerbations in Spain: prospective, observational, multicentric study (OASIS study)

A. Romero Ortiz (Granada, Spain), A. Villar (Barcelona, Spain), E. Cano-Jiménez (Lugo, Spain), M. Rodríguez-Nieto (Madrid, Spain), S. Armengol (Barcelona, Spain), A. Ramon (Barcelona, Spain), M. Morros (Barcelona, Spain)

Source: Virtual Congress 2020 – Clinical aspects of idiopathic pulmonary fibrosis
Session: Clinical aspects of idiopathic pulmonary fibrosis
Session type: E-poster session
Number: 762
Disease area: -

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Romero Ortiz (Granada, Spain), A. Villar (Barcelona, Spain), E. Cano-Jiménez (Lugo, Spain), M. Rodríguez-Nieto (Madrid, Spain), S. Armengol (Barcelona, Spain), A. Ramon (Barcelona, Spain), M. Morros (Barcelona, Spain). Health resource utilisation due to IPF exacerbations in Spain: prospective, observational, multicentric study (OASIS study). 762

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Economic impact of IPF exacerbations in Spain: prospective, observational, multicentric study (OASIS study)
Source: Virtual Congress 2021 – Interstitial lung disease around the world
Year: 2021


Characteristics and clinical management of IPF patients in Spain: prospective, observational, multicentric study (OASIS study).
Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries
Year: 2020


The Spanish national clinical audit on COPD exacerbations (eCOPD). Pilot study: selection of study subjects
Source: Annual Congress 2008 - COPD in the elderly - quality of life and scores in COPD
Year: 2008


REALizing and improving management of COPD in China: A prospective observational study
Source: Virtual Congress 2021 – Inhaled treatments for COPD: real-world data
Year: 2021


Quality of life and healthcare utilisation in cystic fibrosis: a multicentre study
Source: Eur Respir J 2013; 41: 571-577
Year: 2013



An Italian, observational, multicentre trial to describe treatment management in COPD patients: Preliminary results of the MISTRAL study
Source: International Congress 2014 – Monitoring airway diseases with lung function tests
Year: 2014


DuoResp Spiromax adherence, satisfaction and ease of use: findings from a multi-country observational study in patients with asthma and COPD (SPRINT)
Source: International Congress 2018 – Pulmonary drug delivery: inhaler use, devices and technologies
Year: 2018


Adequacy of treatment in COPD patients referred to the emergency room for disease exacerbation: an Italian multicentre observational study (the COXER study)
Source: Annual Congress 2008 - Management of COPD
Year: 2008


General practice and office spirometry in asthma and COPD: preliminary data from the prospective, randomised, comparative ²SPACE² Italian study
Source: Eur Respir J 2004; 24: Suppl. 48, 87s
Year: 2004

An Italian, observational, multicenter trial to describe the therapeutic approach according to COPD GOLD guidelines during three years of observation: The MISTRAL study
Source: International Congress 2014 – Clinical assessment of airway diseases
Year: 2014


An Italian, observational, multicenter trial in female COPD patients: Preliminary data on the women reality in the MISTRAL study
Source: International Congress 2014 – Clinical assessment of airway diseases
Year: 2014


Costs and effects of structured COPD care – An observational, matched-cohort study
Source: Annual Congress 2013 –Early diagnosis and effectiveness of disease management in primary care
Year: 2013

Clinical Assessment of Glycopyrronium in COPD phenotypes and ACOS: Prospective, case control, observational study
Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies
Year: 2019


Efficacy and safety of nintedanib in a Greek multicentre idiopathic pulmonary fibrosis registry: a retrospective, observational, cohort study
Source: ERJ Open Res, 6 (1) 00172-2019; 10.1183/23120541.00172-2019
Year: 2020



Long-term survivalaccording to Czech clinical phenotypes of COPD- Czech multicentre research database of severe COPD
Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities
Year: 2016


Protocol for the EARCO Registry: a pan-European observational study in patients with a1-antitrypsin deficiency
Source: ERJ Open Res, 6 (1) 00181-2019; 10.1183/23120541.00181-2019
Year: 2020



Risk of future exacerbations among COPD patients – a real-world register-based cohort study (AvoidEx)
Source: Virtual Congress 2020 – Airflow obstruction, COPD and comorbidities
Year: 2020




Development of a new prognosis index (BODS) in patients with COPD:a prospective cohort study
Source: International Congress 2018 – What’s hot in rehabilitation in COPD and interstitial lung disease (ILD)?
Year: 2018

Multi-centre research: The experience of a UK, Danish and Dutch qualitative study exploring the meaning of COPD and its exacerbations to patients
Source: Eur Respir J 2003; 22: Suppl. 45, 66s
Year: 2003

Improved outcomes in ex-smokers with COPD: a UK primary care observational cohort study
Source: Eur Respir J, 49 (5) 1602114; 10.1183/13993003.02114-2016
Year: 2017